Publications des agents du Cirad

Cirad

Investigation on the management for patients with echinococcosis treated with albendazole - three PLADs, China, 2019

Qin M., Wang L., Wang Y., Wang X., Lei J., Cheng X., Feng Y., Hou Y., Wang Q., Xue C., Gavotte L., Frutos R.. 2023. China CDC Weekly, 5 (20) : p. 437-441.

DOI: 10.46234/ccdcw2023.083

What is already known about this topic? In China, patients with echinococcosis receive complimentary healthcare services, such as medical treatment, diagnostic examinations, and follow-up care. Despite this, no studies have been conducted to assess the quality of patient management to date. What is added by this report? This study reviewed the medical records of 899 patients who underwent albendazole treatment across 10 endemic counties. Out of 634 evaluable patient files, the proportion of patients with a ratio of actual follow-up and reexamination times to theoretical follow-up and reexamination times =0.8 were both low (21.92% and 23.19%, respectively). What are the implications for public health practices? This study identified weaknesses and specific issues in patient management and proposed feasible recommendations to enhance patient file documentation, follow-up, and reexamination.

Mots-clés : echinococcose; albendazole; santé publique; maladie de l'homme; chine

Documents associés

Article (a-revue à facteur d'impact)

Agents Cirad, auteurs de cette publication :